Mississippi 2026 Regular Session

Mississippi House Bill HB533

Introduced
1/12/26  
Refer
1/12/26  

Caption

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

Impact

Should this bill pass, it will lead to significant amendments in the Mississippi Code, particularly concerning the practice of pharmacy. Specifically, it will redefine the scope of practice for pharmacists, allowing them to include certain diagnostic and treatment services. The bill also permits pharmacists to delegate administrative and technical tasks related to these health services to pharmacy technicians or interns. Furthermore, the legislation mandates that health benefit plans cannot deny reimbursement for services performed by pharmacists that fall within their licensed scope, which aims to equalize the treatment of pharmacists and other prescribing practitioners in insurance contexts.

Summary

House Bill 533 seeks to expand the role of pharmacists in Mississippi by authorizing them to test for and initiate treatment for minor, nonchronic health conditions. This includes conditions like influenza, urinary tract infections, and COVID-19. The bill provides a definition for 'minor, nonchronic health conditions' and details the specific conditions that pharmacists can manage. By enabling pharmacists to perform these tests and treatments, the bill aims to increase access to healthcare, particularly for minor ailments that do not require a physician's consultation.

Contention

While the bill aims to enhance healthcare access, it may raise concerns around the quality of care and the training of pharmacists in managing these health conditions. Critics may argue that such responsibilities should remain with medical doctors or advanced practice providers, particularly for conditions that may require more comprehensive medical evaluations. Additionally, concerns may arise over the standards of training required for pharmacists to perform these tasks effectively, and whether adequate safeguards are in place to protect patients while allowing pharmacists to operate within this expanded scope.

Companion Bills

No companion bills found.

Previously Filed As

MS HB252

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

MS SB2675

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

MS SB2895

Parental consent for minor's healthcare treatment; establish certain provisions related thereto.

MS SB2069

Health insurance; require health benefit plans to follow new procedure related to step therapy protocol for CRF-COPD treatment.

MS HB1615

Implied consent laws; authorize nonadjudication for violation under certain conditions.

MS SB2361

Conditional medical release; revise authority of MDOC.

MS HB119

Health insurance; require reimbursement to pharmacists for certain services and procedures.

MS HB1155

Minors; prohibit health-care providers and institutions from providing health care to without parental consent.

MS HB120

Minors; prohibit health care providers and institutions from providing health care to without parental consent.

MS HB360

Health insurance policies; require coverage for certain obesity treatments.

Similar Bills

NJ A3359

Regulates provision of pharmaceutical services in nursing homes.

NJ S2990

Regulates provision of pharmaceutical services in long-term care facilities.

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

HI SB1245

Relating To Pharmacists.

MD SB562

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

MD HB838

State Board of Pharmacy - Prescriber-Pharmacist Agreements

TX HB3540

Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.